ArticleInternal medicine (Tokyo, Japan)2024

Treatment of Cryptogenic New-onset Refractory Status Epilepticus (C-NORSE) with Tocilizumab.

Yumiko Nakamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.